TD Waterhouse Canada Inc. Reduces Stock Holdings in Agilent Technologies, Inc. $A

TD Waterhouse Canada Inc. lessened its stake in Agilent Technologies, Inc. (NYSE:A) by 95.4% in the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 532 shares of the medical research company’s stock after selling 11,106 shares during the quarter. TD Waterhouse Canada Inc.’s holdings in Agilent Technologies were worth $64,000 at the end of the most recent reporting period.

Other hedge funds also recently made changes to their positions in the company. Stone House Investment Management LLC purchased a new stake in Agilent Technologies during the 1st quarter worth $30,000. Ransom Advisory Ltd acquired a new stake in shares of Agilent Technologies during the first quarter worth approximately $32,000. Central Pacific Bank Trust Division acquired a new stake in Agilent Technologies in the second quarter valued at $33,000. Zions Bancorporation National Association UT bought a new stake in shares of Agilent Technologies in the 1st quarter worth about $38,000. Finally, Costello Asset Management INC acquired a new stake in shares of Agilent Technologies in the 1st quarter valued at about $47,000. Hedge funds and other institutional investors own 87.41% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts have recently commented on the stock. Evercore ISI increased their price target on shares of Agilent Technologies from $128.00 to $140.00 and gave the stock an “in-line” rating in a research report on Tuesday, October 7th. TD Cowen increased their target price on Agilent Technologies from $150.00 to $162.00 and gave the stock a “buy” rating in a report on Tuesday, October 14th. Robert W. Baird lifted their target price on Agilent Technologies from $142.00 to $165.00 and gave the stock an “outperform” rating in a research report on Tuesday. Citigroup upped their price target on Agilent Technologies from $165.00 to $185.00 and gave the company a “buy” rating in a research report on Tuesday. Finally, Rothschild Redb raised shares of Agilent Technologies to a “strong-buy” rating in a report on Wednesday, October 8th. One equities research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and five have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $161.08.

Insider Activity

In other news, CEO Padraig Mcdonnell sold 12,490 shares of the stock in a transaction on Wednesday, November 12th. The stock was sold at an average price of $150.00, for a total value of $1,873,500.00. Following the completion of the transaction, the chief executive officer owned 33,448 shares of the company’s stock, valued at approximately $5,017,200. This represents a 27.19% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Insiders own 0.26% of the company’s stock.

Agilent Technologies Stock Up 2.4%

A stock opened at $157.25 on Wednesday. The stock has a market cap of $44.58 billion, a PE ratio of 36.91, a price-to-earnings-growth ratio of 4.67 and a beta of 1.29. The firm’s 50-day simple moving average is $140.80 and its 200 day simple moving average is $126.03. Agilent Technologies, Inc. has a fifty-two week low of $96.43 and a fifty-two week high of $160.27. The company has a quick ratio of 1.71, a current ratio of 2.25 and a debt-to-equity ratio of 0.53.

Agilent Technologies (NYSE:A) last posted its earnings results on Monday, November 24th. The medical research company reported $1.59 EPS for the quarter, topping the consensus estimate of $1.58 by $0.01. The firm had revenue of $1.86 billion during the quarter, compared to analysts’ expectations of $1.83 billion. Agilent Technologies had a net margin of 17.97% and a return on equity of 25.51%. Agilent Technologies’s quarterly revenue was up 9.4% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.46 EPS. Agilent Technologies has set its Q1 2026 guidance at 1.350-1.380 EPS. FY 2026 guidance at 5.860-6.000 EPS. As a group, sell-side analysts predict that Agilent Technologies, Inc. will post 5.58 EPS for the current year.

Agilent Technologies Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, January 28th. Shareholders of record on Tuesday, January 6th will be given a dividend of $0.255 per share. This is a boost from Agilent Technologies’s previous quarterly dividend of $0.25. The ex-dividend date is Tuesday, January 6th. This represents a $1.02 dividend on an annualized basis and a yield of 0.6%. Agilent Technologies’s payout ratio is presently 23.94%.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.